Tectonic Therapeutic reported $239.89M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alnylam Pharmaceuticals USD 4.22B 168.65M Mar/2026
Celltrion KRW 470.6B 5.07T Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
MacroGenics USD 182.52M 37.42M Mar/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pfizer USD 42.82B 76M Mar/2026
Pharma Mar EUR 273.45M 9.96M Mar/2026
Qiagen NV USD 2B 535.87M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 30.16B 789M Mar/2026
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Sartorius EUR 1.92B 157.2M Mar/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Takeda JPY 3.09T 25.94B Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026